| 1 |
33145616 | Population pharmacokinetics of ATR inhibitor berzosertib in phase I studies for different cancer types. | 2021 Feb |
1 |
| 2 |
33854565 | ATR and p-ATR are emerging prognostic biomarkers and DNA damage response targets in ovarian cancer. | 2020 |
2 |
| 3 |
29890208 | The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma. | 2018 Sep 28 |
1 |
| 4 |
30166399 | ATR Inhibition Is a Promising Radiosensitizing Strategy for Triple-Negative Breast Cancer. | 2018 Nov |
1 |
| 5 |
25010037 | Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970. | 2014 Jul 30 |
1 |